Amyvid (Eli Lilly and Company)
Welcome to the PulseAid listing for the Amyvid drug offered from Eli Lilly and Company. This Radioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
| NON-PROPRIETARY NAME: | Florbetapir F 18 |
| SUBSTANCE NAME: | FLORBETAPIR F-18 |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Radioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-06-01 |
| END MARKETING DATE: | 0000-00-00 |
Amyvid HUMAN PRESCRIPTION DRUG Details:
| Item Description | Amyvid from Eli Lilly and Company |
| LABELER NAME: | Eli Lilly and Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 51(mCi/mL) |
| START MARKETING DATE: | 2012-06-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0002-1200_4bd46cbe-cdc1-4329-a8e7-22816bd7fc33 |
| PRODUCT NDC: | 0002-1200 |
| APPLICATION NUMBER: | NDA202008 |
Other FLORBETAPIR F-18 Pharmaceutical Manufacturers / Labelers:
